MPS Pharmaa (BOM:531686) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is MPS Pharmaa FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MPS Pharmaa's Free Cash Flow for the three months ended in Dec. 2024 was ₹0.00 Mil. MPS Pharmaa's Revenue for the three months ended in Dec. 2024 was ₹0.00 Mil. Therefore, MPS Pharmaa's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, MPS Pharmaa's current FCF Yield % is -11.81%.

The historical rank and industry rank for MPS Pharmaa's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of MPS Pharmaa was 88.30%. The lowest was -13431.17%. And the median was 15.28%.

BOM:531686's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.87
* Ranked among companies with meaningful FCF Margin % only.

MPS Pharmaa FCF Margin % Historical Data

The historical data trend for MPS Pharmaa's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPS Pharmaa FCF Margin % Chart

MPS Pharmaa Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

-13,431.17

MPS Pharmaa Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of MPS Pharmaa's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MPS Pharmaa's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPS Pharmaa's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPS Pharmaa's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MPS Pharmaa's FCF Margin % falls into.

Save Embed

;

Save Embed

;

MPS Pharmaa FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MPS Pharmaa's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-6.501	/	0
	=	%

MPS Pharmaa's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

MPS Pharmaa FCF Margin % Related Terms

Thank you for viewing the detailed overview of MPS Pharmaa's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MPS Pharmaa Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPS Pharmaa Ltd (BOM:531686) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Barakhamba Road, Connaught Place, 703, Arunachal building 19, New Delhi, IND, 110001

Website

https://www.mpspharmaa.com

MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and export of Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory and antibacterials & antibiotics.

MPS Pharmaa Headlines

No Headlines